Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fevzi Altuntas

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 20, 2021
Apheresis in patients with sepsis: A multicenter retrospective studyKaniye Aydin, Serdal Korkmaz, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 12, 2008
Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter studyLeylagul Kaynar, Fevzi Altuntas, Ismet Aydogdu, et al.
Bone Marrow Transplantation|April 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemiasAbdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 3, 2025
Does body mass index affect stem cell yield in healthy donors?Seda Yilmaz, Nazik Okumus, Mert Seyhan, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 25, 2024
Are mesenchymal stem cells still effective in acute GvHD management?Bahar Uncu Ulu, Ipek Yonal Hindilerden, Tugce Nur Yigenoglu, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 8, 2025
Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?Yavuz Katircilar, Abdulkadir Sahin, Muruvvet Seda Aydin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 21, 2025
The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantationHikmetullah Batgi, Tuğba Zorlu, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 21, 2024
Efficacy of Ruxolitinib in the management of chronic GVHDAsli Odabasi Giden, Mehmet Ali Erkurt, Ipek Yonal Hindilerden, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 19, 2024
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?Turgay Ulas, Sinem Namdaroglu, Ipek Yonal Hindilerden, et al.
Journal of Medical Virology|August 11, 2020
The outcome of COVID-19 in patients with hematological malignancyTugce N Yigenoglu, Naim Ata, Fevzi Altuntas, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 20, 2021
Apheresis in patients with sepsis: A multicenter retrospective studyKaniye Aydin, Serdal Korkmaz, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 12, 2008
Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter studyLeylagul Kaynar, Fevzi Altuntas, Ismet Aydogdu, et al.
Bone Marrow Transplantation|April 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemiasAbdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 3, 2025
Does body mass index affect stem cell yield in healthy donors?Seda Yilmaz, Nazik Okumus, Mert Seyhan, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 25, 2024
Are mesenchymal stem cells still effective in acute GvHD management?Bahar Uncu Ulu, Ipek Yonal Hindilerden, Tugce Nur Yigenoglu, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 8, 2025
Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?Yavuz Katircilar, Abdulkadir Sahin, Muruvvet Seda Aydin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 21, 2025
The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantationHikmetullah Batgi, Tuğba Zorlu, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 21, 2024
Efficacy of Ruxolitinib in the management of chronic GVHDAsli Odabasi Giden, Mehmet Ali Erkurt, Ipek Yonal Hindilerden, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 19, 2024
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?Turgay Ulas, Sinem Namdaroglu, Ipek Yonal Hindilerden, et al.
Journal of Medical Virology|August 11, 2020
The outcome of COVID-19 in patients with hematological malignancyTugce N Yigenoglu, Naim Ata, Fevzi Altuntas, et al.
Pageof 9